Recap: IDEXX Laboratories Q1 Earnings - IDEXX Laboratories (NASDAQ:IDXX)

IDEXX Laboratories IDXX reported its Q1 earnings results on Wednesday, May 4, 2022 at 06:30 AM.

Here's what investors need to know about the announcement.

IDEXX Laboratories beat estimated earnings by 0.44%, reporting an EPS of $2.27 versus an estimate of $2.26.

Revenue was up $58.84 million from the same period last year.

Last quarter the company beat on EPS by $0.18 which was followed by a 0.88% increase in the share price the next day.

Here's a look at IDEXX Laboratories's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	1.71	1.91	2.04	1.71
EPS Actual	1.89	2.03	2.34	2.35
Revenue Estimate	784.43M	798.16M	782.99M	737.38M
Revenue Actual	801.09M	810.42M	826.14M	777.71M

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

IDEXX Laboratories management provided guidance for FY 2022, expecting earnings between $8.11 and $8.35 per share.

To track all earnings releases for IDEXX Laboratories visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.